Autoimmune: Phase II trials

Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)

Bortezomib

Phase II

Myasthenia gravis

Germany

Recruiting

Click here for further information


Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis

IGIV-C

Phase II

Myasthenia gravis

USA & Canada

Recruiting

Click here for further information


A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis

IGIV-C

Phase II

Myasthenia gravis

USA

Recruiting

Click here for further information


Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis

HIZENTRA®

Phase II

Myasthenia gravis

USA

Recruiting

Click here for further information


The Evaluation of Belimumab in Myasthenia Gravis

Belimumab

Phase II

Myasthenia gravis

USA, Canada, Germany & Italy

Ongoing, not recruiting

Click here for further information


Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis

CFZ533

Phase II

Myasthenia gravis

Denmark & Germany

Recruiting

Click here for further information


Efficacy of Methotrexate in Myasthenia Gravis

Methotrexate

Phase II

Myasthenia gravis

USA & Canada

Ongoing, not recruiting

Click here for further information


Phase II Trial of Rituximab In Myasthenia Gravis

Rituximab

Phase II

United States

Recruiting

Click here for further information


A Phase 2b/3 Study to Compare Efficacy and Safety of Masitinib to Placebo in the Treatment of Patients With Primary Progressive or Relapse-free Secondary Progressive Multiple Sclerosis

Masitinib

Phase II

Spain

Recruiting

Click here for further information


Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis

Lisinopril

Phase II

United States

Recruiting

Click here for further information